US OptionsDetailed Quotes
RIGL250117P35000
- 0.00
- 0.000.00%
15min DelayClose Jan 3 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover203.51%IV-101.38%PremiumJan 17, 2025Expiry Date17.62Intrinsic Value100Multiplier12DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9544Delta0.0161Gamma0.98Leverage Ratio-0.0211Theta-0.0067Rho-0.94Eff Leverage0.0031Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
No comment yet